Search - SFB 1361

271. Öffentlicher Vortrag von Nina Ruge: Verjüngung ist möglich. Die neuesten Erkenntnisse der Zellbiologie - 27 Juni, 18:00 h

Nina Ruge / Prof. Dr. Dorothee Dormann (IMB/Johannes Gutenberg-Universität Mainz) / Prof. Dr. Peter Baumann (IMB/Johannes Gutenberg-Universität Mainz) / Clemens Hoch (Minister für Wissenschaft und…

272. New publication from the Butter lab on DNA damage repair proteins across the tree of life

The Butter lab in cooperation with the Luke lab used quantitative mass spectrometry to explore DNA damage binders across 11 different species, leading to unique insights into the crosstalk and…

273. Myosin VI in genome stability and aging / Diversity of in vitro end-joining complexes

SFB 1361 Colloquium

274. New publication from associated SFB member Hans-Peter Wollscheid on how nuclear myosin VI maintains replication fork stability

New publication in Nature Communications from associated SFB member Hans-Peter Wollscheid together with the Ulrich lab, Beli lab, and Plückthun lab showing that actin-based motor myosin VI…

275. Role of the cytoskeleton in genome stability / Transposable elements and genome instability

276. RNA-DNA hybrids

277. Good scientific practice – Protecting research integrity

Professional Development Lecture

278. New publication from the Krämer lab on how NOXA accentuates apoptosis induction by a novel histone deacetylase inhibitor

Ashry R, Mustafa AHM, Hausmann K, Linnebacher M, Strand S, Sippl W, Wirth M and Krämer OH (2023) NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor. Cancers…

279. New publication from the Krämer and Hofmann lab on a novel hydroxamic acid derivative

Fischer MA, Mustafa AHM, Hausmann K, Ashry R, Kansy AG, Liebl MC, Brachetti C, Piée-Staffa A, Zessin M, Ibrahim HS, Hofmann TG, Schutkowski M, Sippl W and Krämer OH (2023) Novel hydroxamic acid…

280. My journey from academia to industry – Project management in big pharma

Professional Development Lecture